Invention Grant
US08633317B2 Crystalline salts of thieno[3,2-c]pyridine kinase inhibitors with improved cpy safety profile
失效
噻吩并[3,2-c]吡啶激酶抑制剂的结晶盐，具有改进的cpy安全性
![Crystalline salts of thieno[3,2-c]pyridine kinase inhibitors with improved cpy safety profile](/docs/US/2014-01-21/US08633317B2/abs.jpg.600x600.jpg)
- Patent Title: Crystalline salts of thieno[3,2-c]pyridine kinase inhibitors with improved cpy safety profile
- Patent Title (中): 噻吩并[3,2-c]吡啶激酶抑制剂的结晶盐，具有改进的cpy安全性
-
Application No.: US13156070Application Date: 2011-06-08
-
Publication No.: US08633317B2Publication Date: 2014-01-21
- Inventor: Geoff G. Z. Zhang , Paul J. Brackemeyer , Ahmad Y. Sheikh
- Applicant: Geoff G. Z. Zhang , Paul J. Brackemeyer , Ahmad Y. Sheikh
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agent Susan L. Steele
- Main IPC: A61K31/44
- IPC: A61K31/44 ; C07D513/02
![Crystalline salts of thieno[3,2-c]pyridine kinase inhibitors with improved cpy safety profile](/abs-image/US/2014/01/21/US08633317B2/abs.jpg.150x150.jpg)
Abstract:
Salts of N-(4-{4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]thieno[3,2-c]pyridin-3-yl}phenyl)-N′-(3-fluorophenyl)urea and crystalline forms thereof are suitable pharmaceutical ingredients for pharmaceutical compositions useful in the treatment of disease, for example, cancer.
Public/Granted literature
- US20120203002A1 Crystalline Forms of Kinase Inhibitors Public/Granted day:2012-08-09
Information query
